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In 1999 and 2000, 3 state health departments reported
4 outbreaks of gastrointestinal illness due to Salmonella
enterica serotype Typhimurium in employees, clients, and
client animals from 3 companion animal veterinary clinics
and 1 animal shelter. More than 45 persons and compan-
ion animals became ill. Four independent investigations
resulted in the testing of 19 human samples and >200 ani-
mal samples; 18 persons and 36 animals were culture-pos-
itive for S. Typhimurium. One outbreak was due to
multidrug-resistant S. Typhimurium R-type ACKSSuT, while
the other 3 were due to multidrug-resistant S. Typhimurium
R-type ACSSuT DT104. This report documents nosocomi-
al transmission of S. Typhimurium and demonstrates that
companion animal facilities may serve as foci of transmis-
sion for salmonellae between animals and humans if ade-
quate precautions are not followed.
S
almonella spp. infect an estimated 1.4 million persons
annually in the United States. Although most infections
are self-limiting with diarrhea, vomiting, abdominal
cramps, and fever, severe infections are not uncommon.
Estimates suggest that ≈15,000 people are hospitalized and
>500 deaths occur annually due to Salmonella infections
(1). Food animals are the primary reservoir for human non-
typhoidal  Salmonella  infections; person-to-person trans-
mission of nontyphoidal salmonellae is uncommon in the
United States. Transmission of salmonellae to humans
typically occurs by ingesting meat, dairy products, and
other foods contaminated by animal feces or by cross-con-
tamination from foods contaminated with salmonellae.
Zoonotic transmission of Salmonella spp. can also occur
through direct exposure to the feces of reptiles, farm ani-
mals, pets, pet treats, and other animals (2–10).
Antimicrobial agents such as fluoroquinolones and
third-generation cephalosporins (e.g., ceftriaxone) are
commonly used to treat severe human Salmonella infec-
tions. Resistance to these and other antimicrobial drugs, as
well as multidrug resistance, has increased over the last
several decades (11), partly as a consequence of antimicro-
bial drug use in food animals (2). The use of antimicrobial
agents in companion animals (e.g., dogs and cats) may also
contribute to the development of antimicrobial resistance
in salmonellae, but the impact of this contribution is
unknown. Antimicrobial drug use in companion animals,
therefore, could increase the likelihood of zoonotic trans-
mission of multidrug-resistant salmonellae by generating
drug-resistant strains as well as by making animals more
susceptible to resistant infections (12).
Salmonella outbreaks with illness in animals and
humans have been reported in both equine and companion
animal veterinary facilities (13–19). These reports
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York, New York, USA.commonly describe poor hand washing by employees, eat-
ing in work areas, and prior antimicrobial drug therapy in
humans or animals. Case reports of companion animals
infected with salmonellae have included multidrug-resist-
ant isolates (15,18–22). 
In late 1999 and early 2000, 3 state health departments
reported to the Centers for Disease Control and Prevention
(CDC) outbreaks of gastrointestinal illness in employees
and clients of 3 companion animal veterinary clinics and 1
companion animal shelter. We review these outbreaks,
which demonstrate that companion animal veterinary
facilities can serve as foci of transmission of salmonellae
to animals and humans. Recommendations to prevent fur-
ther outbreaks of salmonellosis associated with companion
animal veterinary facilities were reviewed.
Veterinary Clinic, Idaho
In September 1999, several kittens being treated for
diarrhea at a veterinary clinic (clinic A) died; stool speci-
mens were not collected. Within 2 days of the kittens’
deaths, an employee who had cared for the kittens became
ill with diarrhea. Days later a second employee who cared
for the kittens became ill, as did other employees who had
no direct contact with the kittens. Within 2 weeks, 10 (50%)
of 20 employees of clinic A had experienced diarrhea and
abdominal cramps. The median age of the ill persons was
31 years (range 19–44 years). The median duration of ill-
ness was 7 days (range 4–12 days). Four persons sought
medical care. No one was hospitalized.  
Stool specimens from 5 ill employees yielded salmo-
nellae, which was serotyped at the Idaho Department of
Health and Welfare (IDHW) as Salmonella enterica
serotype Typhimurium. The IDHW tested all S.
Typhimurium isolates received during the outbreak period
by pulsed-field gel electrophoresis (PFGE) and for chlo-
ramphenicol resistance by using disk diffusion. Isolates
were tested at CDC for resistance to 17 antimicrobial
agents by using broth microdilution (Sensititre, Trek
Diagnostic Systems, Cleveland, OH, USA) with Clinical
and Laboratory Standards Institute (formerly NCCLS)
interpretive criteria used to determine antimicrobial sus-
ceptibility (23). The 5 isolates were resistant to ampicillin,
chloramphenicol, kanamycin, streptomycin, sulfamethox-
azole, and tetracycline (R-type ACKSSuT); 2 isolates were
additionally resistant to gentamicin, clavulanic acid,
cephalothin, and ceftriaxone. Isolates were indistinguish-
able by PFGE. Phage testing was performed at CDC
according to the methods of the Laboratory of Enteric
Pathogens, Central Public Health Laboratory, Health
Protection Agency, UK, and all 5 isolates reacted but did
not conform (RDNC).
All ill employees had eaten meals in the clinic in the
days before illness onset. A breakroom was provided for
employees, yet all reported eating on work surfaces
instead. The ill employees had no known common expo-
sures outside clinic A. No additional S. Typhimurium iso-
lates from Idaho were found with chloramphenicol
resistance or with a related PFGE pattern during the out-
break.
Animal Shelter, Minnesota
In Minnesota, S. Typhimurium isolates are routinely
subtyped at the Minnesota Department of Health (MDH)
Public Health Laboratory by PFGE and tested for antimi-
crobial susceptibility. As part of integrated human-animal
surveillance, S. Typhimurium isolates from the Minnesota
Veterinary Diagnostic Laboratory (MVDL) are routinely
forwarded to MDH for PFGE subtyping and antimicrobial
susceptibility testing.
On December 2, 1999, five S. Typhimurium isolates
from cats originating from the same county, submitted by
a regional animal shelter (shelter A), were subtyped at
MDH; all had the same PFGE pattern. The following day,
a human S. Typhimurium isolate routinely submitted to
MDH was determined to have the same PFGE pattern as
the cat isolates. Three additional human cases were identi-
fied retrospectively with dates of illness onset from August
to November; 2 reported recently adopting a kitten from
shelter A. A review of recently diagnosed feline salmonel-
losis cases from shelter A identified 9 cases; all 9 cases
were fatal and originated from multiple sources, but all ill
cats were housed at shelter A. Dates of death for the kittens
ranged from September through late October (Figure 1).
Six of the 9 kittens had been adopted; 5 of the 6 were
returned to shelter A because of illness.
From August 1999 to March 2000, a sample of 7 human
isolates and 9 feline S. Typhimurium isolates were identi-
fied as indistinguishable by PFGE. Figure 2 displays
PFGE patterns for 4 human and 6 feline isolates. All 16
isolates were resistant to ampicillin, chloramphenicol,
streptomycin, sulfamethoxazole, and tetracycline (R-type
ACSSuT). Three cat and 2 human isolates were phage
typed at CDC; all were definitive type 104 (DT104). Six of
the 7 human case-patients with the PFGE outbreak subtype
of S. Typhimurium had a discernable connection to shelter
A; 4 had adopted kittens from shelter A during
August–October 1999. Two additional patients were chil-
dren who attended the same daycare center as a child who
became ill 77 days after adopting 2 kittens from shelter A.
This child had been treated with multiple antimicrobial
drugs in the month before the onset of her salmonella gas-
troenteritis, including cephalexin, amoxicillin, trimetho-
prim-sulfamethoxazole, and ciprofloxacin. Neither of her
2 kittens developed diarrhea, but the outbreak strain of S.
Typhimurium R-type ACSSuT DT104 was recovered from
the stool of one of these cats 115 days after adoption.
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months–23 years). The median duration of illness was 8
days (range 5–11 days). All 7 persons sought medical care;
1 child was hospitalized for 4 nights. One of the ill persons
was treated with ciprofloxacin but continued to shed
Salmonella spp. in stool for at least 214 days after illness
onset. 
After the institution of enhanced infection control pro-
cedures by the shelter staff in October, no further cases of
salmonellosis occurred at the facility. In December 1999,
environmental samples from drains, kennels, and addition-
al cats housed at the shelter were all negative for
Salmonella spp.
Clinic B, Washington
In late 1999, twelve cats were brought to a companion
animal veterinary clinic (clinic B) with diarrhea, vomiting,
anorexia, and lethargy. All 12 cats lived in different homes
and all roamed outdoors. Stool specimens collected from 6
of the 12 yielded S. enterica; all isolates were serotyped at
the National Veterinary Services Laboratory (NVSL) as
Typhimurium. Two of 3 persons who became ill had han-
dled ill cats. The third person had brought his cat to clinic
B during the outbreak for treatment of an unrelated illness.
Stool specimens from the 3 ill persons and 6 cats yielded
S. Typhimurium, R-type ACSSuT DT 104. Isolates were
indistinguishable from each other by PFGE (Figure 3). 
The Field Disease Investigation Unit (FDIU) from the
Washington State University College of Veterinary
Medicine performed a comprehensive investigation.
Medical chart reviews demonstrated that 7 (58%) of the 12
ill cats had been seen at clinic B for an unrelated reason
3–37 days (median 5 days) before gastrointestinal illness
onset; 4 (57%) of these 7 cats had been treated for their
original symptoms with an antimicrobial agent to which
the outbreak strain of S. Typhimurium was later found to
be resistant.
As part of this investigation, 2 controls were selected
from clinic B records for each ill cat. For each case, the
next cat owner listed alphabetically in clinic B’s files, as
well as the next cat seen at the clinic after the ill cat, was
selected as a control. Distance was measured from owner’s
homes to the nearest creek. Affected cats owners’ homes,
regardless of whether the cat’s infection was potentially
nosocomial, were significantly closer to 1 of 2 creeks tra-
versing the community than were control client’s homes
(rank sum test, p<0.01). Water samples collected from the
creeks 2 months after the outbreak were negative for S.
enterica.
Stool specimens for bacterial culture were collected
from additional animals treated at clinic B, including 43
hospitalized cats, 37 outpatient cats, and 23 cats from
households with proven infected cats. Salmonellae were
isolated from 5 (12%) of 43 hospitalized cats, including
the asymptomatic clinic blood donor cat and from 3 (8%)
of 37 cats residing in households with infected cats; no iso-
lates were obtained from sampled outpatient cats. The 6
original culture-positive cats were periodically sampled
and shed salmonellae 3–60 days before becoming culture-
negative. As part of the investigation, specimens from the
remaining 6 original cats (from which no previous speci-
mens had been cultured) were collected; these specimens
were cultured and confirmed to shed the outbreak strain of
S. Typhimurium. Fecal cultures of 26 animals from a local
animal shelter were negative for Salmonella.
Seventy-two environmental samples were collected from
clinic B, from homes of clinic B clients and employees,
and from a local animal shelter. The outbreak strain of
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Figure 1. Date of death among cats and week of illness onset
among human case-patients, Minnesota, 1999.
Figure 2. Pulsed-field gel electrophoresis patterns of human and
feline isolates from Minnesota outbreak,1999. Lanes 1, 2, 8, 14,
and 15 contain Xbal-digested DNA from the standard strain
H9812; lanes 3, 4, 9, and 10 contain human isolates; lanes 5-7,
and 11-13 contain feline isolates. Lanes 3-7 were digested with
Xbal and lanes 9-13 with Blnl.S. Typhimurium was isolated from the floor of the board-
ing area and from the floor and door handles in the clinic
B isolation ward. The outbreak strain was additionally iso-
lated from an environmental sample (a vacuum cleaner
bag) from the house where 2 of the infected cats lived(24).
Salmonella spp. were not isolated from the homes of clin-
ic B employees, nor from the local animal shelter.
The additional Salmonella isolates from animals and
the environmental samples were serotyped at NVSL as S.
Typhimurium and phage typed as DT104. Agar disk-diffu-
sion testing determined the isolates to be R-type ACSSuT.
The original 6 animal isolates, the animal isolates collect-
ed during the investigation, and the human isolates were
indistinguishable by PFGE. 
Ten of the ill cats received empiric antimicrobial thera-
py for their gastrointestinal illness. When antimicrobial
susceptibility results became available, the antimicrobial
agent of the 7 cats still undergoing treatment was changed
to enrofloxacin. Although clinical signs of the affected cats
resolved promptly after initiation of 10-day courses of
enrofloxacin therapy, stool cultures of specimens from 3
cats taken 14–24 days after completion of the course of
enrofloxacin yielded the outbreak strain of S.
Typhimurium.
Clinic C, Washington
In early 2000, several cats were brought to a compan-
ion animal veterinary clinic (clinic C) with diarrhea; no
stool specimens were collected. Three days after their cat
was treated for vomiting and diarrhea, 2 children became
ill with diarrhea. Six days after treating an ill cat, a clinic
C employee also became ill with diarrhea. The duration of
illness for the 3 ill persons was 5–7 days, and all 3 persons
sought medical care. One child was hospitalized for 2
nights, but salmonellae were never cultured from this
child’s stool. Stool specimens obtained from the ill clinic
employee, an asymptomatic clinic employee, and the other
child yielded salmonellae, which were identified as S.
Typhimurium at the Washington State Department of
Public Health Laboratory. Clinic C was the only known
association between the 3 ill persons. 
During this period, stool specimens submitted from 1
dog and 3 cats with diarrhea yielded salmonellae; isolates
were serotyped as S. Typhimurium by NVSL. Two days
before diarrhea onset, the 4 animals had been treated as
outpatients at clinic C for unrelated reasons; 3 of the 4
received amoxicillin before diarrhea onset.
The FDIU performed an investigation in clinic C,
including bacterial cultures of stool specimens from addi-
tional animals (n = 96) and environmental samples from
clinic C and employee and client homes (n = 66). S.
Typhimurium was isolated from 1 cat and 2 dogs (1
asymptomatic). The cat exhibited anorexia and dehydra-
tion; a stool specimen was collected. This cat had not been
seen at clinic C during the outbreak, but several of its
housemates had been seen at clinic C for conditions other
than diarrhea during the outbreak. One of the 2 dogs
boarded at the clinic during the outbreak and had a single
episode of bloody diarrhea; its asymptomatic housemate
had not been seen by clinic C.
None of the environmental samples collected from clin-
ic C yielded salmonellae. The outbreak strain of S.
Typhimurium was identified in the contents of the home
vacuum cleaner bags from 2 clinic C employees and the
asymptomatic owner of a culture-confirmed cat (24). The
S. Typhimurium isolates from the 2 ill persons, 7 animals,
and the 3 vacuum bags were all demonstrated at CDC to be
S. Typhimurium R-type ACSSuT DT104. These isolates
were additionally indistinguishable by PFGE at the FDIU
Laboratory, Pullman, Washington (Figure 3) by using stan-
dard protocols (25) and were indistinguishable from those
of the clinic B outbreak. 
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Figure 3. Pulsed-field gel electrophoresis patterns associated with
the Washington state outbreaks, 1999 and 2000. Lanes A and F
are standards; lane B is cat, clinic B; lane C is cat, clinic C; lanes
D and E are human isolates. (For confidentiality reasons,
Washington Department of Health did not identify which human
isolates were from which outbreak.) Human and cat isolates are
indistinguishable.Discussion
Four outbreaks of multidrug-resistant S. Typhimurium
associated with companion animal veterinary clinics or
shelter facilities occurred in the United States in late 1999
and early 2000. In each facility, employees, clients, or
both, became infected after animal illness. An outbreak in
an Idaho clinic was caused by multidrug-resistant S.
Typhimurium R-type ACKSSuT with 2 isolates demon-
strating additional resistance to ceftriaxone, an antimicro-
bial agent commonly used to treat children with severe
Salmonella infections. Outbreaks in 2 Washington clinics
and a Minnesota animal shelter were caused by multidrug-
resistant S. Typhimurium R-type ACSSuT DT104. 
In 1999, S. Typhimurium R-types ACSSuT, AKSSuT,
and ACKSSuTwere the most prevalent multidrug-resistant
phenotypes among Salmonella isolates in the United
States. Twenty-one percent of all Salmonella isolates of
human origin tested at the National Antimicrobial
Resistance Monitoring System (NARMS) in 1999 were
multidrug-resistant; 6% were S. Typhimurium R-type
ACSSuT, 2% were R-type AKSSuT, and 1% were R-type
ACKSSuT (11).
In each outbreak discussed, the veterinary facility or
animal shelter was the only common exposure for infected
persons, which demonstrated that infected animals brought
to companion animal veterinary clinics and animal shelters
can be foci for nosocomial transmission to other animals
and for zoonotic transmission to humans. These outbreaks
illustrate 1) the hazards of occupational zoonotic transmis-
sion of Salmonella spp. from ill animals to clinic employ-
ees, 2) the hazards of zoonotic transmission of Salmonella
spp. to clients/pet owners, 3) the risk for nosocomial trans-
mission of Salmonella spp. between animals within veteri-
nary facilities and animal shelters, and 4) the potential for
environmental contamination to serve as an ongoing
source of infection. 
The use of antimicrobial agents prescribed by veterinar-
ians may contribute to increased transmission of mul-
tidrug-resistant  Salmonella spp. between animals by
lowering the infectious dose required for infection to occur
or by increasing the duration of illness when an infected
animal is treated with an ineffective drug (12,26,27). The
risk for Salmonella transmission between animals in vet-
erinary facilities is likely increased by the presence of ani-
mals with increased susceptibility to multidrug-resistant
Salmonella infection due to treatment with antimicrobial
agents for other conditions. Fluoroquinolone antimicrobial
therapy did not eliminate fecal shedding of susceptible
strains of salmonellae in 3 cats and 1 person from whom
follow-up cultures were obtained. This finding is similar to
other results in humans, which demonstrate that fluoro-
quinolone treatment is associated with longer duration of
carriage (28). 
Although person-to-person transmission of nonty-
phoidal Salmonella spp. is rare in the United States, this
mode of transmission appears likely in the Minnesota out-
break in which an ill child apparently infected classmates
in a daycare center. Several instances of probable second-
ary transmission to animals within client households after
apparent primary nosocomial infection were demonstrated
during these outbreaks. The isolation of Salmonella spp.
from client-owned vacuum cleaner bags illustrated the
potential for such secondary transmission. Additional iso-
lation of the outbreak strain from environmental surfaces
in the Washington clinic B investigation reinforces the
findings of previous studies, which demonstrated the
potential to transmit salmonellae through environmental
contact (29,30).
Veterinarians should expect, at least occasionally, to
evaluate animals infected with Salmonella spp. Following
these outbreaks, recommendations for infection prevention
and control were formulated to help prevent future out-
breaks of salmonellosis in association with companion ani-
mal facilities (31). Recommendations include wearing
gloves while cleaning cages and treating animals, then
immediately removing the gloves and washing hands
when the task is completed. No eating or drinking should
be allowed in animal treatment and holding areas, and
feces-contaminated areas should be immediately cleaned
and disinfected. Clear warnings of the risk for transmission
of Salmonella spp. should be given when pets with proba-
ble salmonellosis are encountered. Veterinarians should
consider culturing the stools of animals with diarrhea and
should be aware of the increased risk for infection with
multidrug-resistant salmonellae in animals who are given
antimicrobial drugs for other conditions. Because use of
antimicrobial agents contributes to increasing resistance
and facilitates transmission of multidrug-resistant salmo-
nellae, promoting guidelines aimed at improving appropri-
ate use of antimicrobial agents may help prevent
transmission of multidrug-resistant Salmonella infections
in veterinary facilities (31).
Although recommendations have been formulated and
disseminated (31), outbreaks of multidrug-resistant
Salmonella spp. occurred in an animal shelter in Idaho in
2003–2004 (18) and in New York in 2003 (19). Continued
outbreaks suggest that more outreach and education
regarding the potential for nosocomial and zoonotic out-
breaks such as these should be directed to the veterinary
community.
Additionally, states should consider integrating human
and veterinary surveillance systems and educating the vet-
erinary community on their public health role. In our
report, the outbreak in 1 state may have been undetected
without the routine comparison of human and veterinary
laboratory data. Considering recent outbreaks of zoonotic
Multidrug-resistant Salmonella Typhimurium
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tions, the continued threat of avian influenza, and the num-
ber of agents of bioterrorism that are zoonotic in nature,
the integration of human and veterinary surveillance sys-
tems is of utmost importance in our public health infra-
structure.  
Acknowledgments 
We thank the NVSL Salmonella serotyping laboratory, Ben
Holland for phage typing, and Robert Adair and Wallis DeWitt
for PFGE images.
Funds from the Washington State University Field Disease
Investigation Unit supported the Washington portion of the inves-
tigations.
Some information contained in this article was presented at
the American Veterinary Medical Association convention in
Boston, Massachusetts, in July 2001 and at the International
Conference on Emerging Infectious Diseases in Atlanta, Georgia,
in March 2002.
Dr. Wright, a veterinarian and lieutenant commander in the
United States Public Health Service, is now the project coordina-
tor for a sentinel surveillance project tracking antimicrobial
drug–resistant gonorrhea at CDC’s National Center for HIV, STD,
and TB Prevention. Her interests also include zoonotic diseases,
pediatric vaccination and policies, and antimicrobial resistance. 
References
1. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, et
al. Food-related illness and death in the United States. Emerg Infect
Dis. 1999 5:607–25.
2. Angulo FJ, Johnson KR, Tauxe RV, Cohen ML. Origins and conse-
quences of antimicrobial-resistant nontyphoidal Salmonella: implica-
tions for the use of fluoroquinolones in food animals. Microbial Drug
Resist. 2000,6:77–83.
3. Centers for Disease Control and Prevention. Reptile-associated sal-
monellosis—selected states, 1996–1998. MMWR Morb Mortal Wkly
Rep. 1999;48:1009–13.
4. Sato Y, Mori T, Koyama T, Nagase H. Salmonella virchow infection
in an infant transmitted by household dogs. J Vet Med Sci.
2000;62:767–9.
5. Tauni MA, Osterlund A. Outbreak of Salmonella typhimurium in cats
and humans associated with infection in wild birds. J Small Anim
Pract. 2000;41:339–41.
6. Holmberg SD, Wells JG, Cohen ML. Animal-to-man transmission of
antimicrobial resistant Salmonella: investigations of U.S. outbreaks,
1971–1983. Science. 1984;225:833–5.
7. Lyons RW, Samples CL, DeSilva HN, Ross KA, Julian EM, Checko
PJ. An epidemic of resistant Salmonella in a nursery. JAMA.
1980;243:546–7.
8. Pitout JDD, Reisbig MD, Mulvey M, Chui L, Louie M, Crowe L, et
al. Association between handling of pet treats and infection with
Salmonella enterica serotype Newport expressing the AmpC β-lacta-
mase, CMY-2. J Clin Microbiol. 2003;41:4578–82.
9. Clark C, Cunningham J, Ahmed R, Woodward D, Fonseca K, Isaacs
S, et al. Characterization of Salmonella associated with pig ear dog
treats in Canada. J Clin Microbiol. 2001;39:3962–8.
10. White DG, Datta A, McDermott P, Friedman S, Qaiyumi S, Ayers S,
et al. Antimicrobial susceptibility and genetic relatedness of
Salmonella serovars isolated from animal-derived dog treats in the
USA. J Antimicrob Chemother. 2003;52:860–3.
11. Centers for Disease Control and Prevention. National Antimicrobial
Resistance Monitoring System 1999 annual report. Atlanta: US
Department of Health and Human Services; 1999. 
12. Anderson AD, Nelson JM, Baker NL, Rossiter S, Angulo FJ. Public
health consequences of use of antimicrobial agents in agriculture. In:
Smulders JM, Collins JD, editors. Food safety assurance and veteri-
nary public health vol 3: risk management strategies: monitoring and
surveillance. Wageningen, the Netherlands: Wageningen Academic
Publishers; 2005. p. 173–84.
13. Hartmann FA, Callan RJ, McGuirk SM, West SB. Control of salmo-
nellosis caused by drug-resistant Salmonella anatum in horses at a
veterinary teaching hospital and measures to prevent future infec-
tions. J Am Vet Med Assoc. 1996;209:629–31.
14. Ketaren K, Brown J, Shotts EB, Hornsby PS, McClelland CL. Canine
salmonellosis in a small animal hospital. J Am Vet Med Assoc.
1981;179:1017–8.
15. Timony JF, Neibert HC, Scott FW. Feline salmonellosis: a nosocomi-
al outbreak and experimental studies. Cornell Vet. 1978;68:211–9.
16. Ewart SL, Schott HC, Robinson RL, Dwyer RM, Eberhart SW,
Walker RD. Identification of sources of Salmonella organisms in a
veterinary teaching hospital and evaluation of the effects of disinfec-
tants on detection of Salmonella organisms on surface materials. J
Am Vet Med Assoc. 2001;218:1145–51.
17. Alinovi Ca, Ward MP, Couetil LL, Wu CC. Detection of Salmonella
organisms and assessment of a protocol for removal of contamination
in horse stalls at a veterinary teaching hospital. J Am Vet Med Assoc.
2003;223:1640–4.
18. Dunn J, Carter K, Tengelsen L, Hahn C, Nunnery J, Shulman S, et al.
Salmonella Typhimurium DT104 infections among persons adopting
cats from an animal shelter. Abstract #552; p. 148. 42nd Annual
Meeting of the Infectious Disease Society of America. Sept 30–Oct 3,
2004. Boston, Massachusetts.
19. Cherry B, Burns A, Johnson GS, Pfeifer H, Dumas N, Barrett D, et al.
Salmonella Typhimurium outbreak associated with veterinary clinic.
Emerg Infect Dis. 2004:10:2249–51.
20. Evans S, Davies R. Case control study of multiple-resistant
Salmonella typhimurium DT104 infection of cattle in Great Britain.
Vet Rec. 1996;139:557–8. 
21. Low JC, Tennant B, Munro D. Multiple-resistant Salmonella
typhimurium DT104 in cats. Lancet. 1996;348:1391. 
22. Wall PG, Threllfall EJ, Ward LR, Rowe B. Multiresistant Salmonella
typhimurium DT104 in cats: a public health risk. Lancet.
1996;348:471.
23. National Committee for Clinical Laboratory Standards. Performance
standards for antimicrobial susceptibility testing:  eleventh informa-
tional supplement. NCCLS document M100-S12. Wayne (PA): The
Committee; 2001.
24. Rice DH, Hancock DD, Roozen PM, Szymanski MH, Scheenstra BC,
Cady KM, et al. Household contamination with Salmonella enterica.
Emerg Infect Dis. 2003;9:120–2.
25. Centers for Disease Control and Prevention. Standardized molecular
subtyping of foodborne bacterial pathogens by pulsed-field gel elec-
trophoresis. The National Molecular Subtyping Network for
Foodborne Disease Surveillance. Centers for Disease Control and
Prevention, Atlanta, Ga, 1998. Available at http://www.cdc.gov/
pulsenet/protocols/ecoli_salmonella_shigella_protocols.pdf
26. Bohnhoff FE, Miller CP. Enhanced susceptibility to Salmonella infec-
tion in streptomycin-treated mice. J Infect Dis. 1962;111:117–27.
27. Barza M. Potential mechanisms of increased disease in humans from
antimicrobial resistance in food animals. Clin Infect Dis.
2002;34(Suppl 3):123–5.
RESEARCH
1240 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 8, August 200528. Sirinavin S, Thavornnunth J, Sakchainanont B, Bangtrakulnonth A,
Chongthawonsatid S, Junumporn S. Norfloxacin and azithromycin
for treatment of nontyphoidal Salmonella carriers. Clin Infect Dis.
2003;37:685–91.
29. Barker J, Bloomfield SF. Survival of Salmonella in bathrooms and
toilets in domestic homes following salmonellosis. J Appl Microbiol.
2000;89:137–44.
30. Josephson KL, Rubino JR, Pepper IL. Characterization and quantifi-
cation of bacterial pathogens and indicator organisms in household
kitchens with and without the use of a disinfectant. J Appl Microbiol.
1997;83:737–50.
31. Centers for Disease Control and Prevention. Outbreaks of multidrug-
resistant Salmonella Typhimurium associated with veterinary facili-
ties—Idaho, Minnesota, and Washington, 1999. MMWR Morb
Mortal Wkly Rep. 2001;50:701–4.
Address for correspondence: Frederick J. Angulo, Centers for Disease
Control and Prevention, National Center for Infectious Diseases, Division
of Bacterial and Mycotic Diseases, Foodborne and Diarrheal Diseases
Branch, 1600 Clifton Rd, Atlanta, GA, 30333, USA; fax: 404-371-4444;
email: fangulo@cdc.gov
Multidrug-resistant Salmonella Typhimurium
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 8, August 2005 1241
Search   past   issues   of   EID   at   www.cdc.gov/eid